California Code of Regulations › Title 15 - Crime Prevention and Corrections › Division 3 - Adult Institutions, Programs and Parole › Chapter 1 - Rules and Regulations of Adult Operations and Programs › Subchapter 8 - Pilot Programs › Article 1 - Pilot Programs › Section 3999.22 - Medication Assisted Treatment for Substance Abuse Disorders Pilot Program

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
Memorandum
Date: March 13, 2017
To:
Executive Leadership
Deputy Directors
California Correctional Health Care Services
Executive Leadership
Division of Health Care Services
Louie Escobell, Chief Executive Officer
Muhammad Farooq, M.D., MBA, MPH, Chief Medical
								Executive
Alex Serrano, RN, Chief Nurse Executive
Victor Jordan, Ph.D., Chief of Mental Health
California Institution for Men
James Elliot, MA, CCHP, Chief Executive Officer
Leslie Taylor, M.D., Chief Medical Executive
Nyreith Adeyemi, MBA, BSN, RN, PHN, Chief Nurse
								Executive
Michael Hewitt, Psy.D, Chief of Mental Health
California Institution for Women
From:
Diana L. Toche, D.D.S., Undersecretary
Health Care Services
California Department of Corrections and
								Rehabilitation
Richard Kirkland
Chief Deputy Receiver
Subject:
Medication Assisted Treatment for Substance Abuse
								Disorders Pilot Program
This memorandum constitutes certification, pursuant to Penal
						Code (PC) section
						5058.1, subdivision
						(b)(2), for California Correctional Health Care Services (CCHCS) and the California
						Department of Corrections and Rehabilitation (CDCR) to proceed with a Medication
						Assisted Treatment for Substance Abuse Disorders Pilot Program (Pilot). Senate Bill
						(SB) 843 was enacted with the adoption of Chapter 33, Statutes of 2016 which adds PC
						section
						2694.5 and requires
						the CDCR to establish a Pilot program at one or more institutions that will provide
						a medication assisted treatment model for inmates with a history of substance abuse
						problems. SB 826, Chapter 23, Statutes of 2016 appropriated $2,500,000 in funding to
						be used to develop the Pilot.
PILOT PROJECT
						LOCATIONS
The Pilot will be conducted at California Institution for Men
						and California Institution for Women.
PILOT PROJECT
						DURATION
The Pilot will be in effect for three years and will expire by
						operation of law at the end of this period unless it is promulgated through the
						Administrative Procedure Act prior to expiration.
PILOT OVERVIEW
The Pilot shall offer a continuum of evidence-based care that
						is designed to meet the needs of the individuals being served and that is
						appropriate for a correctional setting. In establishing the Pilot, pursuant to SB
						843, CDCR is required to consider the following:
1.
Access to services during a patient's
					 enrollment in the pilot program;
2.
Access to subacute detoxification and
					 medical detoxification, as necessary;
3.
Comprehensive pre-treatment and
					 post-treatment assessments;
4.
Ongoing evaluation of a patient's program needs and progress at least every
					 90 days, and appropriate adjustment of treatment based on that
					 evaluation;
5.
Services
					 provided by professionals for whom substance use disorder treatment is within the
					 scope of their practice;
6.
Referrals for medication assisted care and prescription of medication
					 assisted treatment;
7.
Provision of behavioral health services, including the capacity to treat
					 co-occurring mental illness;
8.
Access to medication assisted treatment throughout the period of
					 incarceration up to and including immediately prior to release;
					 and
9.
Linkages to
					 community-based treatment upon parole.
FISCAL IMPACT
SB 826 appropriated $2,500,000 in funding to be used to
						develop the Pilot. The funding is available for encumbrance or expenditure until
						June 30, 2019.
REPORTING
						REQUIREMENTS
SB 843 requires CDCR to report to the fiscal and appropriate
						policy committees of the Legislature by March 1, 2017, and each March thereafter
						during the tenure of the Pilot. The report shall include the following
						elements:
1.
The planned patient
					 capacity of the program;
2.
The number of patients enrolled in the program;
3.
The number of patients who leave the
					 treatment program against medical advice and the number of patients who are
					 discharged from the program prior to achieving their treatment
					 goals;
4.
The
					 percentage of patients with negative urine toxicology screens for illicit substances
					 during treatment and post-treatment while incarcerated; and
5.
The number of patients who are
					 successfully linked to post-release treatment.
CERTIFICATION
We certify that this Pilot qualifies for exemption under Penal
						Code sections 5058.1 and
						2694.5.
cc: Angela Ponciano, Associate Director, Mental Health
						Program, CDCR
Michael Golding, M.D., Statewide Chief Psychiatrist, Mental
						Health Program, CDCR
Thomas Gilevich, Assistant Chief Counsel, Office of Legal
						Affairs, CDCR
Tim Lockwood, Chief, Regulation and Policy Management Branch,
						CDCR
Jasinda Muhammad, Assistant Deputy Director, Human Resources,
						CCHCS
Duane Reeder, Associate Director, Fiscal Services,
						CCHCS
Lara Saich, Chief, Risk Management Branch,
						CCHCS
1. New section
						filed 4-3-2017; operative 4-3-2017 pursuant to Penal Code section
						5058.1(c).
						Submitted to OAL for filing with the Secretary of State and printing only pursuant
						to Penal Code section
						5058.1(b)
						(Register 2017, No. 14). Section shall lapse by operation of law on 4-3-2020
						pursuant to Penal Code section
						2694.5(a)
						unless formally adopted as a regulation pursuant to Chapter 3.5 (commencing with
						section 11340) of Part 1 of Division 3 of Title
						2 of the Government Code.